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Summary.-The MLr antigen, a mammary tumour virus-induced antigen on the
surface of GR thymic lymphoma cells (GRSL) can be modulated from the cell
surface upon incubation with specific antiserum for 1-2 h at 37°C, followed by
washing the cells. In contrast, a number of other cell-surface antigens on these
GRSL cells cannot be modulated under similar conditions. These antigens include
histocompatibility antigens of the H-2 complex (H-2.8 of the K-end and H-2dx(D) of
the H-2dX haplotype) and two thymic markers, TL1-2 and Thyl 2. Antigenic modula-
tion of MLr as tested by trypan-blue exclusion and by chromium51 release does not
lead to a measurable change in the expression of H-2K, H-2D, TL and Thyl 2 antigens.
These results could be confirmed by absorption analysis. The latter analysis showed
that the number of antigenic sites per cell are about the same for MLr and the two
H-2 antigens, while TL antigens are scarcer and Thyl-2 antigens are more abundant.
The procedure of antigenic modulation showed that the MLr antigen resides on
MTVgp52, the major protein of the envelope. There was no evidence of internal
proteins, such as MTVp27, on the surface of GRSL cells.
ANTIGENIC MODULATION of a cell-surface
antigen is the phenomenon in which cells
can become negative for the expression of
an antigen after incubation at 370C with a
specific antibody. It was first described
for the TL antigenic system in mice by
Boyse et al. (1963) and confirmed by Old
et al. (1968). It has since been reported for
a number of apparently unrelated cell-
surface antigens, such as Epstein-Barr
virus-associated membrane antigens
(Smith et al., 1968), murine leukaemia
virus-related antigens (Aoki & Johnson,
1972; Joachim et al., 1977), an antigen on
human breast-cancer cells (Nordquist et
al., 1977), HL-A antigens on human
leucocytes (Sadeghee et al., 1975), measles
virus-induced cell-surface antigen (Joseph
& Oldstone, 1975) and, finally, for ML and
MLr antigens related to murine mammary
tumour virus by our group (Calafat et al.,
1-976; Feltkamp et al., 1978) and by
Strzadala et al. (1977). For a recent review
on the phenomenon of antigenic modula-
tion, also called "lysostrip", especially for
the TL antigens, see Old & Stockert
(1977).
The question can be asked whether anti-
genic modulation of a cell-surface antigen
leads to changes in expression of other
antigens on the same cell surface. Would
molecules adjacent to the modulated one
show an increased expression, or would
they "comodulate"? Since redistribution
of antigens on crosslinking with bivalent
antibodies precedes the modulation pro-
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cess, it may be that surrounding antigens
become redistributed too, a phenomenon
comparable to co-capping (Schrader et al.,
1975). Old et al. (1968) were able to show
that antigenic modulation of TL antigens
leads to an increased expression of H-2D
antigens, which are themselves non-
modulable.
The "linkage" on the cell surface of
viral and histocompatibility antigens may
imply a mechanism of H-2-controlled
susceptibility to the virus-induced neo-
plasm (for review, see Steeves & Lilly,
1977), as described in the murine Type C
oncovirus system. Since the major histo-
compatibility complex (H-2D region) was
shown to control resistance to mammary
tumorigenesis by exogenous murine mam-
mary-tumour viruses (Muhlbock & Dux,
1974) it was thought worth while to study
the possible interaction, if it should occur,
between the modulable mammary tumour
virus-induced cell-surface antigens and the
non- or hardly modulable antigens of the
H-2K and H-2D end.
As an experimental model for such
studies we chose ascites tumours in the
GR mouse strain. These tumours are trans-
planted thymic lymphomas (GRSL cells)
expressing the so-called MLr antigen
(Hilgers et al., 1975a) an antigen similar
or even identical to ML present on thymic
lymphomas of the DBA/2 mouse strain
(Stuck et al., 1964; Strzadala et al., 1977).
Similar studies on the possible molecular
relationship between mammary tumour
virus-induced antigens and major histo-
compatibility antigens, were carried out
on L-1210 cells from the DBA strain by
Strzadala et al. (1977).
GRSL cells produce very few, if any,
extracellular virions or Type B particles,
but an abundance of intracytoplasmic A
particles (Calafat et al., 1974). The pre-
cursor polypeptide for MTVgag proteins
(Pr73) does not seem to become phos-
phorylated in GRSL cells, and does not
convert in the Pr76 peptide. The Pr73gag
precursor protein is quite stable, is the
major protein of the intracytoplasmic A
particle and is not found on the cell sujr-
face. The precursor of the envelope pro-
teins of MTV (Pr73env) is also expressed
in GRSL cells and present on the cell sur-
face as shown by lactoperoxidase-cata-
lysed labelling with I25iodine. This pre-
cursor is hardly processed, though some
MTVgp52, the major envelope structural
protein of MTV, can be found. These
recent studies by our group (Nusse et al.,
1979) are an indication that the MLr anti-
gen resides on proteins coded for by the
env region of MTV. Similar conclusions
can be drawn from the work of Westen-
brink et al. (1978) for the ML antigen on
L-1210 cells and for the MLr antigen on
GRSL cells.
MATERIALS AND METHODS
Cells.-Thymic lymphoma cells. called
GRSL cells (Hilgers et al., 1975a), were used
as well as normal lymphoid cells of the GR
strain. In the studies reported here the 18th
spontaneous thymic lymphoma was used
(GRSL18) betwieen the 20-60th transplant
generations in ascites. GRSL18 was main-
tained by weekly i.p. injections of 107 cells,
in young adult GR mice ofeither sex, washed
x 3 in Earle's balanced salt solution after
removal. The usual harvest of cells after one
wreek of intraperitoneal growth was 3-9 x 108
cells.
Antisera.-All antisera were inactivated by
incubation for 30 min at 56°C. The rabbit
anti-MTV serum was prepared by 4 or more
1-3 monthly injections of purified, Tween-
ether-treated B particles from C3H mammary
tumours. The first injection was with incom-
plete Freund's adjuvant, and later injections
with complete Freund's. The antiserum was
absorbed in vivo by injecting 1 ml i.p. in an
MTV- young male mouse, usually of the
BALB/c strain, and recovered by bleeding
the mouse the next day. It is thus a mixture
of specific rabbit antibodies to MTV and
mouse immunoglobulins. Normalrabbitserum
was treated in the same way for control
experiments. Such "rigorous" in vivo absorp-
tions are needed to obtain specificity, and are
superior to the usual in vitro absorption pro-
cedures as shown previously (Hilgers et al.,
1972).
The two antisera prepared against MTV
543J. HILGERS, A. SONNENBERG AND R. NUSSE
proteins purified according to described pro-
cedures (Nusse etal., 1978) (i.e. anti-MTVgp52
and anti-MTVp27) were both absorbed in vivo
before use in the cytotoxicity assays. They
are both precipitating sera and exhibit
strong immunofluorescence on fixed GRSL
cells. Anti-MTVp27 shows a brilliant pattern
resembling the distribution of intracytoplas-
mic A particles in the GRSL cells, while the
anti MTVgp52 shows a more diffuse pattern
on the fixed cells. Possible contaminating
antibodies to other virion proteins are not
detectable with conventional immunological
assays like immunodiffusion and gelelectro-
phoresis following immune precipitation.
The antiserum to H-2-8 antigen was pre-
pared byweeklyinjections ofB1O-Mlymphoid
cells in (BlO xA.SW)F1 hybrid mice. H-2-8
represents a public specificity of the K-end
in the H-2dx haplotype. An antiserum against
the (largely unknown) D-end of the H-2dx
halotype was prepared by injecting GR
lymphoid cells in the (BALB/c x B1O.M)F1
hybrid. The antiserum is called H-2dx(D).
For details on the H-2 haplotype of the GR
strain see Zachairova et at. (1975). The anti-
serum to the Thyl-2 antigen described first
by Reif& Allen (1964) wasprepared byweekly
injections of thymocytes of the C3H/HeAf
strain (Thyl 2) into the AKR/FuRdA (Thy-
1 1) strain. Antiserum to TL antigens was
prepared by weekly injections of A/BrA
(TL1-2 3) thymocytes in A/TL-/MA mice.
Both A strains are of the Hl2a haplotype.
Analysis ofthe TL antigens present on GRSL
cells and GR thymocytes is presented else-
where (Hilgers et al., 1979). GRSL cells show
additional TL specificities, compared with
thymocytes; they are most likely TLI -2-4,
while thymocytes are TL2. Since the anti-
serum is against TL1-2-3 the TL antigens are
designated TL1-2.
Complement.-Normal rabbit sera from
selected rabbits were used as a source of
complement. For absorption of naturally
occurring heteroantibodies, 9 parts ofcomple-
ment were mixed with one part 0-IM EDTA.
The mixture was incubated with mouse
lymphoid cells for 1 h at t0C on a shaker. After
incubation the mixture was centrifuged and
one part of 0dIM CaCl2 was added before
aliquotting and storage at -70°C. A second
identical absorption using GRSL cells was
occasionally necessary, to maintainthe < 10%
dead cells in the complement controls.
Trypan-blue exclusion cytotoxicity test.-
Equal volumes of 20 ,ul cells (5 x 106 cells/ml)
antiserum dilutions and complement (1/3)
wereincubated for45 minat37TC inmicrotitre
plates. After incubation the plates were put
on ice and the number of dead cells counted
immediately on addition of20 pl0.5% trypan
blue. For absorption analysis, dilutions of
cells (1/1 is 2 x 108 cells) with antiserum in the
appropriate dilution at a ratio of 5:1 were
incubated overnight at 4TC on a shaker. After
incubation, the tubes were centrifuged for
15 min at 2400 g and 20 pl of supernatant
was removed and put in microtitre wells for
the trypan-blue test as well as the 51Cr-
release assay.
510C-release test.-One ml (2 x 107) cells
was labelled with 100-150 ,uCi Na-51 chromate
in phosphate-buffered saline. After 40 min
incubation at 37TC in a waterbath on a shaker
the cells were washed x 3 and resuspended
till a concentration of 5 x 106 ml was reached.
This was followed by a cytotoxicity test as
described for the trypan-blue exclusion assay.
After 45 min at 37TC the microtitre plates
were put on ice and 140 pi medium was added
to the 60 ,u of reaction mixture present in
each well. The amount of released isotype
was counted for 4 min in a gammacounter and
the results were expressed as the percentage
of maximal isotope release, obtained by
freezing and thawing x 3 the labelled GRSL
cells.
The percentage of dead cells is now:
released counts/total counts, where total
counts is the count after freezing and thawing
x 3 which, in fact, is about 88% of the total
count in the cells. This method is described by
Wigzell (1965).
Antigenic modulation procedures.-GRSL
cells were washed x 3 with Earle's balanced
salt solution. A total of 5 x 106 cells were
preincubated at 37°C with the different sera.
Aliquots ofthe cell were taken at 2, 5, 15, 30,
60 and 120 min and immediately cooled till
4°C on ice and diluted x 4 with Medium 199
containing 2% foetal calfserum. After centri-
fugation the aliquots were washed twice
again before the cells were used in a trypan-
blue exclusion or 51Cr-release assay. In other
studies aliquots were taken at 120 min only
and processed similarly. The preincubation
was done under continuous shaking, and even
extra shaking by hand with 15 min intervals.
Shaking during preincubation and extensive
washing thereafter are essential to obtain
optimal results.
544ANTIGENIC MODULATION OF MTV ENVELOPE ANTIGEN
RESULTS
Fig. 1 shows that preincubation with
antiserum to MLr, followed by washing of
the cells at different intervals, followed by
incubation with normal serum (rabbit
serum processed for in vivo absorption in
the mouse) and complement in a regular
cytotoxicity test (45 min at 37TC) leads to
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FiG. 1.-Antigenic modulation ofMLrantigen.
GRSL18 cells were "preincubated" with
antiserum to MLr (1/16), washed at various
times after preincubation (a) and subse-
quently treated with complement in a
regular trypan-blue exclusion test. "ns"
refers to preincubations with normal serum
for 120 min. (b) Preincubation with anti-
MLr serumis followed bya cytotoxicity test
with normal serum (0 O) and anti-
MLr serum ( 0). "cc" is comple-
ment controls.
a rapid increase in killing of the target
cells for about 15 min, and then a slow
decrease in killing, extending over aperiod
of 1-2 h. Two hours' preincubation with
anti-MLr serum dilutions of 1/8 to 1/16
(titre of antiserum ranges from 1/32 to
1/128) is generally sufficient to "remove"
all MLr from the cell surface, preventing
the fixation of complement and subse-
quent death of the cells. Our previous
studies (Van Blitterswijk et al., 1975,
1979) have provided evidence that the
MLr antigen is shed from the cell surface,
rather than pinocytosed. Fig. 1 further-
more shows that preincubation with anti-
serum to MLr in a 1/8 dilution for 2 h,
followed by washing and a cytotoxicity
test with the same antiserum, leads to
negativity for the antigen when compared
to the control cells preincubated with
normal serum.
From Fig. 2 it appears that antigenic
modulation cannot be detected under
comparable circumstances for all other
antigens tested; H-2K and H-2D antigens
ofthe H-2dx haplotype are non-modulable
on GRSL cells, and the same holds true
for the thymic markers TL1 2 and Thyl2.
It may seem surprising that no modula-
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FIG. 2.-Antigenic modulation tests for various antigens. Preincubation was carried out with antisera
against MLr, H-2-8(K), H-2dx (D), Thyl-2 and TL1-2 3 with, for each antigen, normal sera as control
(0 O or CD O). In all cases except MLr, the preincubation with antiserum followed by incubation with the same antiserum leads to higher cytotoxicity than in the control situation.
"cc" is complement controls.
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FIG. 3. Specificity of antigenic modulation of MLr. Preincubation with anti-MLr (0) serum and
control serum (O) for 120min is followed bycytotoxicity testsforMLr, H-2-8(K), TL1-2 andThyl*2.
Two types of cytotoxicity tests (trypan blue and 5lCr-release) were applied on the same batch of
preincubated GRSL18 cells, as described in Materials and Methods. "cc" is complement controls.
preincubation: /MLr preincubation: NS preincubation: /H-2dx(D)
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FIG. 4.- Specificity of antigenic modulation of MLr compared with H-2dx(D) antigen. Preincubation
with anti-MLr, anti H-2dx (D) and lnormal serum (NS) for 120 min was followed by washing and
cytotoxicity tests with anti-MLr (0 0) and anti-H-2dx(D) (0 O). "cc" is complement
controls.
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FIG. 5. Specificity ofantigenic modulation of
MLr, measured by cytotoxic absorption.
Preincubation with anti-MLr ( 0)
and normal serum (O 0 ) was for 2 h at
37°C. Counted numbers of cells were then
used for absorption analysis (target cells
for MLr, H-2-8(K) and TL1.2 were
GRSL18 cells, whilst thymocytes were used
as target cells for Thyl-2). Note that the
number of cells for 50% absorption for the
various antigens is +4 x 107 (MLr),
+ 4 x 107 (H-2-8), ± 16 x 107 (TL1 2),
+4x 106 (Thyl-2). This implies that the
density of Thyl-2 antigenic sites is much
higher than that of MLr and H-2-8 (both
x 10 less) and TL1 2 ( x 40 less). "cc' is
complement controls.
tion was found for TL antigens on these
leukaemia cells, the antigenic system with
which this phenomenon was first dis-
covered. However, it has been reported
that TL antigens are non-modulable on a
variety of target cells, whilst they are
modulable on other cell types.
Since it has recently been observed that
certain interactions between cell-surface
antigens occur on the cell surface of a
variety oflymphoid cells, notably between
viral and histocompatibility antigens, it
seemed worth while to study whether anti-
genic modulation of the viral antigen,
MLr, would lead to a change in expression
of histocompatibility or other antigens.
Such experiments are presented in Fig. 3,
using both the conventional trypan-blue
exclusion test and a 51Cr-release assay. It
can be seen that both assays record the
antigenic modulation process, although
this is somewhat less clear for the 51Cr-
release assay.
If MLr modulated cells are tested for
the expression ofH-2K, TL1 2 andThy1l2,
as shown in Fig. 3 by the 2 tests, no sig-
nificant change can be found from the
control cell preincubated with normal
serum. Fig. 4 shows this for H-2dx(D) and
also shows again that H-2D antigens are
non-modulable on GRSL cells. These
results could be confirmed by absorption
analysis, as shown in Fig. 5. No changes in
absorption capacity of modulated cells
compared to control cells could be ob-
served for H-2K, TLI 2 and Thyl.2. Note
in this figure that the number of antigenic
sites varies considerably (though it is hard
to determine exact numbers by absorption
analysis, and these numbers depend on the
exact dilution of antiserum used for
absorption). MLr appears to be present on
the cell surface in comparable density to
H-2 antigens, less dense than Thyl2 anti-
gen and denser than TLI 2 antigen. Com-
parable densities are found for H-2K and
H-2D antigens (results not shown).
It was still doubtful whether the MLr
antigen resides on envelope proteins of
MTV (MTVgp52) only. Recent advances
in the preparation of antisera against
purified proteins of MTV opened the
possibility of studying this question. It
appears that rabbit anti-MTVgp52 is
clearly cytotoxic for GRSL, whilst anti-
MTVp27 is not (Fig. 6). The anti-
MTVgp52 serum does not react with
normal thymocytes or lymphnode cells,
suggesting MTV specificity, at least after
in vivo absorption. Since gp52 is known to
be an envelope protein and p27 a core pro-
tein of MTV, it seemed likely that the
MLr antigen would reside on an envelope
protein or its precursor. The phenomenon
of antigenic modulation found for the
MLr antigen was used to test this hypo-
thesis further.
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Fia. 6. Cytotoxicity tests for MTVgp52 (0) and MTVp27 (U) in GRSL18 cells, compared with
thymocytes and lymphnode cells. "cc" is complement controls.
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FIG. 7. Antigenic modulation tests for MLr and MTVgp52. Preincubation with normal serum (NS),
anti-MLr and anti-MTVgp52 was for 2 h at 37°C. This was followed by washing and regular cyto-
toxicity tests with anti-MLr (0 O) and anti MTVgp52 ( 0) to show that modulation
of MLr leads to loss of MTVgp52 from the surface and vice versa. "cc" is complement controls.
Fig. 7 shows the results. The antigen on
the cell surface discovered with the anti-
MTVgp52 serum was modulable, like the
MLr antigen. Antigenic modulation of
MLr leads to loss of MTVgp52, whereas
antigenic modulation ofMTVgp52 leads to
a loss of the MLr antigen from the cell
surface. This suggests that MLr is present
to the envelope proteins of MTV on the
cell surface of the GRSL cells. MTVp27
was not discovered with these assays on
the cell surface of GRSL cells. Also, it was
impossible to modulate MLr or MTVgp52
from the cell by pretreatment with anti-
serum to the major core protein, MTVp27.
DISCUSSION
The MLr antigen present on envelope
proteins of MTV is a highly modulable
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antigen on the GRSL cell surface. It is in
this respect different from other antigens
on the GRSL cells, such as H-2K, H-2D,
TL and Thyl. It is tempting to speculate
that the high modulability is a functional
aspect ofthe MLr-carrying protein: it may
be needed after crosslinking inside the cell
of gag protein with env proteins, for the
budding process and subsequent release
of the mature virion, the B particle. In
case crosslinking with gag proteins is
hampered, our hypothesis to explain the
impaired maturation of Type B particles
in GRSL cells, the envelope proteins
Pr73enV and gp52 still seem to be shed
from the cell surface in vesicles (Van
Blitterswijk et al., 1975, 1979). These
vesicles represent selected rigid domains
of the GRSL cell surface, and are com-
parable in their physical membrane pro-
perties with the membrane of the B
particle.
The complete loss of expression of MLr
after modulation with specific antibodies
at 37°C for 1-2 h does not produce any
measurable change in expression of other
cell-surface markers of the GRSL cell
surface. This was a surprise in view of the
clear relationship between certain Type C
virus-induced cell-surface antigens and
H-2 antigens (Bubbers et al., 1976;
Bubbers & Lilly, 1977). Since MLr antigen
can be induced to cap on early passages of
GRSL cells (Hilgers et al., 1975b) we used
co-capping procedures for H-2 and MLr to
try to provide evidence for a possible
association on the cell surface between
viral and H-2 antigens, but no co-capping
was found (e.g. between H-2dx(D) and
MLr). However, more specific reagents for
various subloci inside the H-2 region may
still provide evidence for such a relation-
ship. Another experiment in which the
possible enrichment of H-2 and TL anti-
gens on the purified membranous vesicles
from GRSL cells (enriched in the MLr
antigen) was measured by quantitative
absorption analysis, again failed to show
the hypothetical relationship between
MTV and H-2 (Van Blitterswijk & Hilgers,
unpublished).
In conclusion, antigenic modulation of
the MLr antigen, residing on envelope
proteins of MTV, is a highly specific pro-
cess, perhaps representing a functional
aspect of budding and release of virions.
It does not seem to impair or alter ex-
pression of normal cell-surface antigens,
including those of the major histocom-
patibility complex.
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